gc1111
Recombinant proteinexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2010 (NCT01301898)
Timeline
Indications
Studied for
Mechanism of action
- Epithelial cellsSupplementation
Epithelial cells supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- gc1111
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03920540 | Phase 3 | Mar 9, 2017 | Green Cross Corporation, Sungkyunkwan University |
| NCT01301898 | Phase 1/Phase 2 (Phase 2) | May 1, 2010 | Green Cross Corporation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Green Cross Corporation | For profit | 2 | 2 | 2 | 2010 |
| Sungkyunkwan University | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1